From: Cultural Issues in Using the SF-36 Health Survey in Asia: Results from Taiwan
Scale (Choice Range) | Item | Missing | Mean | SD | PF | RP | BP | GH | VT | SF | RE | MH |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Physical Functioning (1–3) | PF1 | 1.1% | 2.44 | 0.62 | 0.51 a | 0.40 | 0.31 | 0.34 | 0.22 | 0.2 | 0.14 | 0.13 |
 | PF2 | 1.1% | 2.87 | 0.38 | 0.65 a | 0.33 | 0.29 | 0.25 | 0.17 | 0.18 | 0.05 | 0.11 |
 | PF3 | 1.1% | 2.91 | 0.32 | 0.59 a | 0.29 | 0.28 | 0.18 | 0.11 | 0.14 | 0.07 | 0.06 |
 | PF4 | 1.0% | 2.75 | 0.48 | 0.58 a | 0.32 | 0.28 | 0.23 | 0.17 | 0.15 | 0.11 | 0.12 |
 | PF5 | 1.2% | 2.96 | 0.22 | 0.60 a | 0.25 | 0.25 | 0.18 | 0.16 | 0.18 | 0.13 | 0.10 |
 | PF6 | 1.0% | 2.88 | 0.36 | 0.58 a | 0.29 | 0.32 | 0.22 | 0.15 | 0.16 | 0.11 | 0.11 |
 | PF7 | 0.8% | 2.85 | 0.39 | 0.53 a | 0.33 | 0.2 | 0.23 | 0.23 | 0.21 | 0.19 | 0.18 |
 | PF8 | 0.8% | 2.92 | 0.30 | 0.61 a | 0.36 | 0.22 | 0.17 | 0.17 | 0.22 | 0.17 | 0.10 |
 | PF9 | 0.9% | 2.98 | 0.17 | 0.51 a | 0.19 | 0.16 | 0.12 | 0.07 | 0.10 | 0.09 | 0.05 |
 | PF10 | 0.8% | 2.98 | 0.16 | 0.42 a | 0.18 | 0.12 | 0.12 | 0.10 | 0.13 | 0.13 | 0.10 |
Role Physical (1–2) | RP1 | 0.9% | 1.83 | 0.37 | 0.33 | 0.63 a | 0.29 | 0.28 | 0.17 | 0.29 | 0.26 | 0.08 |
 | RP2 | 1.0% | 1.80 | 0.40 | 0.31 | 0.58 a | 0.27 | 0.33 | 0.21 | 0.29 | 0.35 | 0.14 |
 | RP3 | 1.0% | 1.84 | 0.37 | 0.43 | 0.63 a | 0.35 | 0.32 | 0.18 | 0.28 | 0.22 | 0.12 |
 | RP4 | 1.0% | 1.87 | 0.34 | 0.42 | 0.54 a | 0.32 | 0.31 | 0.26 | 0.30 | 0.23 | 0.19 |
Bodily Pain (1–6) | BP1 | 0.2% | 4.88 | 1.02 | 0.33 | 0.31 | 0.60 a | 0.40 | 0.28 | 0.29 | 0.17 | 0.25 |
 | BP2 | 1.1% | 4.53 | 0.65 | 0.37 | 0.41 | 0.60 a | 0.37 | 0.28 | 0.42 | 0.26 | 0.23 |
General Health (1–5) | GH1 | 0.0% | 3.05 | 0.97 | 0.28 | 0.33 | 0.33 | 0.56 a | 0.41 | 0.24 | 0.17 | 0.30 |
 | GH2 | 2.7% | 3.85 | 1.07 | 0.19 | 0.30 | 0.34 | 0.56 a | 0.34 | 0.26 | 0.21 | 0.27 |
 | GH3 | 2.5% | 3.94 | 0.96 | 0.20 | 0.23 | 0.25 | 0.54 a | 0.37 | 0.21 | 0.16 | 0.32 |
 | GH4 | 2.6% | 3.86 | 1.08 | 0.29 | 0.28 | 0.28 | 0.45 a | 0.32 | 0.27 | 0.16 | 0.28 |
 | GH5 | 2.5% | 3.80 | 0.92 | 0.27 | 0.31 | 0.37 | 0.68 a | 0.46 | 0.30 | 0.21 | 0.40 |
Vitality (1–6) | VT1 | 1.2% | 4.34 | 1.09 | 0.18 | 0.23 | 0.21 | 0.42 | 0.58 a | 0.34 | 0.26 | 0.52 |
 | VT2 | 1.2% | 4.14 | 1.09 | 0.20 | 0.15 | 0.23 | 0.44 | 0.63 a | 0.33 | 0.25 | 0.59 |
 | VT3 | 1.2% | 4.47 | 0.90 | 0.23 | 0.24 | 0.24 | 0.33 | 0.46 a | 0.32 | 0.26 | 0.44 |
 | VT4 | 1.0% | 4.11 | 0.90 | 0.16 | 0.17 | 0.27 | 0.35 | 0.53 a | 0.35 | 0.23 | 0.53 |
Social Functioning (1–5) | SF1 | 0.1% | 4.44 | 0.69 | 0.18 | 0.31 | 0.33 | 0.28 | 0.29 | 0.41 a | 0.39 | 0.41 |
 | SF2 | 2.5% | 3.91 | 0.84 | 0.25 | 0.32 | 0.32 | 0.31 | 0.43 | 0.41 a | 0.30 | 0.42 |
Role Emotional (1–2) | RE1 | 0.3% | 1.74 | 0.44 | 0.17 | 0.31 | 0.18 | 0.20 | 0.27 | 0.37 | 0.61 a | 0.32 |
 | RE2 | 0.2% | 1.71 | 0.45 | 0.17 | 0.32 | 0.19 | 0.21 | 0.26 | 0.33 | 0.64 a | 0.29 |
 | RE3 | 0.3% | 1.69 | 0.46 | 0.11 | 0.22 | 0.19 | 0.20 | 0.29 | 0.30 | 0.50 a | 0.32 |
Mental Health (1–6) | MH1 | 1.2% | 4.07 | 1.10 | 0.11 | 0.12 | 0.21 | 0.28 | 0.34 | 0.26 | 0.22 | 0.40 a |
 | MH2 | 1.5% | 4.69 | 0.92 | 0.15 | 0.12 | 0.17 | 0.29 | 0.52 | 0.38 | 0.29 | 0.61 a |
 | MH3 | 1.2% | 4.31 | 1.02 | 0.14 | 0.12 | 0.24 | 0.34 | 0.54 | 0.37 | 0.32 | 0.56 a |
 | MH4 | 1.2% | 4.53 | 0.91 | 0.11 | 0.12 | 0.19 | 0.31 | 0.54 | 0.41 | 0.28 | 0.63 a |
 | MH5 | 1.0% | 4.50 | 1.07 | 0.11 | 0.13 | 0.17 | 0.34 | 0.60 | 0.37 | 0.27 | 0.61 a |